AACR-Kids Beating Cancer Margaret Guedes Monosomy 7 Legacy Cancer Research Grant

About this Opportunity

Supports innovative research that advances biological understanding, identifies therapeutic vulnerabilities, improves response assessment, addresses relapse and enhances survivorship in monosomy 7 acute myeloid leukaemia (AML) and related high-risk cytogenetic subtypes.

Who Can Apply

A doctoral degree (PhD, MD, MD/PhD or equivalent) in a related field.
An independent (non-mentored) investigator position at an academic, medical or research institution anywhere in the world.
No citizenship or geographic restrictions.
Active AACR membership in good standing by the submission deadline.
Not eligible: candidates for a further doctoral degree, employees or subcontractors of a US federal government entity or for-profit private industry, and holders of another AACR grant at the same time.
Eligibility is assessed at the start of the grant term (1 April 2027).

Ready to apply?

Apply Now

You will be taken to the funder's own website. Applications, guidelines and final eligibility decisions are managed by the funder, not by IVAN Research Institute.

Other Open Opportunities

The World Academy of Sciences (UNESCO): Research Continuity... TWAS-SISSA-Lincei Research Cooperation Visits Programme The Bosarge Family Foundation-Waun Ki Hong Scholar Award for...

← Back to Grant Opportunities

At a Glance

Funder American Association for Cancer Research (AACR)

Status Open

Deadline 1 December 2026 Applications close at 1:00 PM US Eastern Time via ProposalCentral. Decision: February 2027; grant term starts 1 April 2027

Funding US$300,000 over 3 years

Thematic Area Monosomy 7 AML and other high-risk acute myeloid leukaemia subtypes

Apply Now